148 related articles for article (PubMed ID: 2572498)
1. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus.
Badenhoop K; Schwarz G; Trowsdale J; Lewis V; Usadel KH; Gale EA; Bottazzo GF
Diabetologia; 1989 Jul; 32(7):445-8. PubMed ID: 2572498
[TBL] [Abstract][Full Text] [Related]
2. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha gene polymorphisms: association with type I (insulin-dependent) diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Trowsdale J; Usadel KH; Gale EA; Bottazzo GF
J Immunogenet; 1989 Dec; 16(6):455-60. PubMed ID: 2577113
[TBL] [Abstract][Full Text] [Related]
4. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.
Pociot F; Briant L; Jongeneel CV; Mölvig J; Worsaae H; Abbal M; Thomsen M; Nerup J; Cambon-Thomsen A
Eur J Immunol; 1993 Jan; 23(1):224-31. PubMed ID: 8093442
[TBL] [Abstract][Full Text] [Related]
5. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
[TBL] [Abstract][Full Text] [Related]
7. Monocyte function in IDDM patients and healthy individuals.
Mølvig J; Pociot F; Baek L; Worsaae H; Dall Wogensen L; Christensen P; Staub-Nielsen L; Mandrup-Poulsen T; Manogue K; Nerup J
Scand J Immunol; 1990 Sep; 32(3):297-311. PubMed ID: 1698309
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals.
Henson V; Maclaren N; Riley W; Wakeland EK
Immunogenetics; 1987; 25(3):152-60. PubMed ID: 2881884
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
Kumar N; Kaur G; Tandon N; Mehra N
Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
[TBL] [Abstract][Full Text] [Related]
10. Association of four HLA class III region genomic markers with HLA haplotypes.
Pei J; Choo SY; Spies T; Strominger JL; Hansen JA
Tissue Antigens; 1991 May; 37(5):191-6. PubMed ID: 1685263
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in the HLA-B region with extended haplotypes.
Egea GE; Yunis I; Spies T; Strominger J; Awdeh ZL; Alper CA; Yunis EJ
Immunogenetics; 1991; 33(1):4-11. PubMed ID: 1671666
[TBL] [Abstract][Full Text] [Related]
12. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic markers for autoimmune diseases of the endocrine system.
Badenhoop K
Klin Wochenschr; 1990; 68 Suppl 21():10-4. PubMed ID: 1973965
[TBL] [Abstract][Full Text] [Related]
14. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
Robinson DM; Holbeck S; Palmer J; Nepom GT
Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
[TBL] [Abstract][Full Text] [Related]
15. The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls.
Whichelow CE; Hitman GA; Raafat I; Bottazzo GF; Sachs JA
Eur J Immunogenet; 1996 Dec; 23(6):425-35. PubMed ID: 8971540
[TBL] [Abstract][Full Text] [Related]
16. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.
Wolf E; Spencer KM; Cudworth AG
Diabetologia; 1983 Apr; 24(4):224-30. PubMed ID: 6407886
[TBL] [Abstract][Full Text] [Related]
17. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.
Bouma G; Crusius JB; Oudkerk Pool M; Kolkman JJ; von Blomberg BM; Kostense PJ; Giphart MJ; Schreuder GM; Meuwissen SG; Peña AS
Scand J Immunol; 1996 Apr; 43(4):456-63. PubMed ID: 8668926
[TBL] [Abstract][Full Text] [Related]
18. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
Wilson AG; de Vries N; Pociot F; di Giovine FS; van der Putte LB; Duff GW
J Exp Med; 1993 Feb; 177(2):557-60. PubMed ID: 8426126
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes.
Monos DS; Kamoun M; Udalova IA; Csanky E; Cizman B; Turetskaya RL; Smirnova JB; Zharkov VG; Gasser D; Zmijewski CM
Hum Immunol; 1995 Oct; 44(2):70-9. PubMed ID: 8847231
[TBL] [Abstract][Full Text] [Related]
20. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
